Safety Results IIIa: TEAE by Adverse Events Distribution in JMP® Clinical
In our recent paper, CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation 1 ,2 , we followed FDA NDA (New Drug Application) or CR (Clinical Reviews) templates to show how drug sa...
Wenjun_Bao_JMP